1 Antibody-drug conjugates 2 Conjugation technology 3 Payload-linker strategies 4 Cancer therapy 5 Drug efficacy
1 Antibody-drug conjugates
2 Conjugation technology
3 Payload-linker strategies
4 Cancer therapy
5 Drug efficacy
Revolutionary Cancer Treatment: Lonza and Qurient Unite!
🌟 Lonza's Synaffix and Qurient Therapeutics unite for dual-payload ADCs, enhancing cancer treatment with innovative cytotoxic agents! 💊🔬🚀
Lilly’s $5B Virginia Facility: 650 Jobs Coming!
**Excerpt:** 🌟 Eli Lilly is investing $5B in a VA facility, creating 650 jobs and focusing on innovative antibody-drug conjugates! 💼🏗️
Revolutionizing ADC Manufacturing: Boost Efficiency and Safety!
Unlock the future of ADC manufacturing! 🚀 Discover innovations that boost efficiency, ensure safety, and reduce risks. 🔬💡📈 Join the discussion! 💬
Ofichem Boosts Drug Development with New Acquisition!
Ofichem 📈 has acquired Meribel Pharma’s Uppsala site 💊, enhancing drug development and expanding its Nordic client base! 🌍🔗
Revolutionary Technology Boosts Next-Gen Cancer Treatments!
Unlock the future of cancer therapy! 💉✨ Discover how novel conjugation and payload-linker technology transforms antibody-drug conjugates (ADCs). 🔬🚀
